Cargando…

Corrigendum: Considerations for Phage Therapy Against Mycobacterium abscessus

Detalles Bibliográficos
Autores principales:	Senhaji-Kacha, Abrar, Esteban, Jaime, Garcia-Quintanilla, Meritxell
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319093/ https://www.ncbi.nlm.nih.gov/pubmed/34335555 http://dx.doi.org/10.3389/fmicb.2021.722831

Ejemplares similares

Considerations for Phage Therapy Against Mycobacterium abscessus
por: Senhaji-Kacha, Abrar, et al.
Publicado: (2021)

Alternatives to Antibiotics against Mycobacterium abscessus
por: Broncano-Lavado, Antonio, et al.
Publicado: (2022)

Bacteriophage–Antibiotic Combination Therapy against Pseudomonas aeruginosa
por: Santamaría-Corral, Guillermo, et al.
Publicado: (2023)

Phage Therapy for Mycobacterium Abscessus and Strategies to Improve Outcomes
por: Hashemi Shahraki, Abdolrazagh, et al.
Publicado: (2021)

Teicoplanin – Tigecycline Combination Shows Synergy Against Mycobacterium abscessus
por: Aziz, Dinah B., et al.
Publicado: (2018)

In vitro and intracellular inhibitory activities of nosiheptide against Mycobacterium abscessus
por: Zhu, Rui, et al.
Publicado: (2022)

Phages in Food Industry Biocontrol and Bioremediation
por: Cristobal-Cueto, Pablo, et al.
Publicado: (2021)

Mycobacterium abscessus subsp. abscessus Is Capable of Degrading Pseudomonas aeruginosa Quinolone Signals
por: Birmes, Franziska S., et al.
Publicado: (2017)

Mycobacterium abscessus: Shapeshifter of the Mycobacterial World
por: Ryan, Keenan, et al.
Publicado: (2018)

Reporter-Based Assays for High-Throughput Drug Screening against Mycobacterium abscessus
por: Gupta, Rashmi, et al.
Publicado: (2017)

Extreme Drug Tolerance of Mycobacterium abscessus “Persisters”
por: Yam, Yee-Kuen, et al.
Publicado: (2020)

Novel Screen to Assess Bactericidal Activity of Compounds Against Non-replicating Mycobacterium abscessus
por: Berube, Bryan J., et al.
Publicado: (2018)

Tedizolid Activity Against Clinical Mycobacterium abscessus Complex Isolates—An in vitro Characterization Study
por: Tang, Ying Wei, et al.
Publicado: (2018)

Unusually high clarithromycin resistance in Mycobacterium abscessus subsp. abscessus isolated from human gastric epithelium
por: Chouhan, Deepak, et al.
Publicado: (2023)

Genome Sequence of Mycobacterium abscessus Phage phiT45-1
por: Amarh, Elizabeth D., et al.
Publicado: (2021)

Genome Sequence of Mycobacterium abscessus Phage phiT46-1
por: Amarh, Elizabeth D., et al.
Publicado: (2021)

Sitafloxacin Expresses Potent Anti-Mycobacterium abscessus Activity
por: He, Siyuan, et al.
Publicado: (2022)

Mycobacterium abscessus Strain Morphotype Determines Phage Susceptibility, the Repertoire of Therapeutically Useful Phages, and Phage Resistance
por: Dedrick, Rebekah M., et al.
Publicado: (2021)

Increased Virulence of Outer Membrane Porin Mutants of Mycobacterium abscessus
por: de Moura, Vinicius C. N., et al.
Publicado: (2021)

Glycopeptidolipids, a Double-Edged Sword of the Mycobacterium abscessus Complex
por: Gutiérrez, Ana Victoria, et al.
Publicado: (2018)

Genomic Comparisons Reveal Microevolutionary Differences in Mycobacterium abscessus Subspecies
por: Tan, Joon L., et al.
Publicado: (2017)

Mycobacterium abscessus and β-Lactams: Emerging Insights and Potential Opportunities
por: Story-Roller, Elizabeth, et al.
Publicado: (2018)

Rifabutin: A Repurposing Candidate for Mycobacterium abscessus Lung Disease
por: Dick, Thomas
Publicado: (2020)

Editorial: Mycobacterium abscessus; The Paradox of Low Pathogenicity and High Virulence
por: Byrd, Thomas F., et al.
Publicado: (2022)

Unusual prophages in Mycobacterium abscessus genomes and strain variations in phage susceptibilities
por: Amarh, Elizabeth D., et al.
Publicado: (2023)

Rufomycin Exhibits Dual Effects Against Mycobacterium abscessus Infection by Inducing Host Defense and Antimicrobial Activities
por: Park, Cho Rong, et al.
Publicado: (2021)

Mycobacterium abscessus complex: A Review of Recent Developments in an Emerging Pathogen
por: Victoria, Laura, et al.
Publicado: (2021)

Epetraborole Is Active against Mycobacterium abscessus
por: Ganapathy, Uday S., et al.
Publicado: (2021)

Relationship between Antibiotic Susceptibility and Genotype in Mycobacterium abscessus Clinical Isolates
por: Li, Bing, et al.
Publicado: (2017)

Lsr2 Is an Important Determinant of Intracellular Growth and Virulence in Mycobacterium abscessus
por: Le Moigne, Vincent, et al.
Publicado: (2019)

Controlling Extra- and Intramacrophagic Mycobacterium abscessus by Targeting Mycolic Acid Transport
por: Viljoen, Albertus, et al.
Publicado: (2017)

Virulence Mechanisms of Mycobacterium abscessus: Current Knowledge and Implications for Vaccine Design
por: Ferrell, Kia C., et al.
Publicado: (2022)

Antibacterial activity of the novel oxazolidinone contezolid (MRX-I) against Mycobacterium abscessus
por: Gao, Shan., et al.
Publicado: (2023)

Antibacterial activity of the novel compound Sudapyridine (WX-081) against Mycobacterium abscessus
por: Nie, Wenjuan, et al.
Publicado: (2023)

Efficacy of PBTZ169 and pretomanid against Mycobacterium avium, Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum in BALB/c mice models
por: Zheng, Luyao, et al.
Publicado: (2023)

Unique Features of Mycobacterium abscessus Biofilms Formed in Synthetic Cystic Fibrosis Medium
por: Belardinelli, Juan M., et al.
Publicado: (2021)

The Diverse Cellular and Animal Models to Decipher the Physiopathological Traits of Mycobacterium abscessus Infection
por: Bernut, Audrey, et al.
Publicado: (2017)

Canaliculitis por Mycobacterium abscessus subsp. abscessus
por: Tello, María Nieves Carmona, et al.
Publicado: (2021)

Rifabutin Is Active against Mycobacterium abscessus Complex
por: Aziz, Dinah Binte, et al.
Publicado: (2017)

Rifabutin Is Active against Mycobacterium abscessus in Mice
por: Dick, Thomas, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2bb8kkl102nt17crc4p8919ule